This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. (INO) shed 1.40% to $1.41 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.11% to 49,760.56 and the NASDAQ Composite Index falling 0.71% to 26,088.20.
This was the stock's second consecutive day of losses.
Inovio Pharmaceuticals Inc. closed 52.67% below its 52-week high of $2.98, which the company achieved on September 9th.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson &amp; Johnson (JNJ) rose 1.28% to $224.26, Statera Biopharma Inc. (STAB) fell 50.00% to $0.00, and Pfizer Inc. (PFE) rose 0.23% to $25.87.
Trading volume (3.0 M) eclipsed its 50-day average volume of 2.5 M.
Data source: Dow Jones Market Data, FactSet. Data compiled May 12, 2026.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
05-12-26 1725ET

LABU

Inovio Pharmaceuticals Inc. (INO) shares fell 1.40% to $1.41 on Tuesday, marking the second consecutive day of losses. The stock is currently 52.67% below its 52-week high of $2.98. In comparison, Johnson & Johnson (JNJ) rose 1.28%, while Pfizer Inc. (PFE) increased by 0.23%. The overall market showed mixed results, with the Dow Jones up 0.11% and NASDAQ down 0.71%. Trading volume for Inovio was 3.0 million, surpassing its 50-day average of 2.5 million.

MarketWatch Automated

Inovio Pharma

Direxion S&P Biotech Bull 3X

iShares Biotechnology ETF

SPDR S&P Biotech

Proshares Ultra Nasdaq Biotech

VanEck Biotech ETF

First Trust NYSE Arca Biotech Index Fd

Dow Jones Industrial Average

NASDAQ Composite Index

Johnson & Johnson

Pfizer

Factset Research

Inovio Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared To Competitors